BILBREY JOHN P
SEC CIK 1268386 · EDGAR
BoughtSold
Most active insiders at CL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wallace Noel R. | COB, Pres, CEO, Dir | — | $33.98M |
| 2 | SUTULA STANLEY J III | CFO | — | $9.22M |
| 3 | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | — | $5.70M |
| 4 | Massey Sally | CHRO | — | $2.36M |
| 5 | Daniels Jennifer | CLO, Sec | — | $2.08M |
| 6 | Hazlin John | Chief Growth Off | — | $1.98M |
| 7 | Malcolm Gregory | EVP, Ctrl | — | $1.41M |
| 8 | CAHILL JOHN T | Dir | — | $389.4K |
| 9 | Fishbone Betsy | CLO, Sec | — | — |
| 10 | GRANT SHANE | COO, Americas | — | — |
| 15 | BILBREY JOHN P | Dir | — | — |
Transactions 42
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 16:15 | 2026-07-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $89.45 | +265 | 40.2K | +0.7% | +$23.7K | |
| D | 2026-05-13 16:45 | 2026-05-11 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $0.00 | +2,075 | 39.8K | +5% | $0 |
| 2026-04-03 16:04 | 2026-04-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $89.05 | +266 | 37.7K | +0.7% | +$23.7K | |
| 2026-01-06 | 2026-01-02 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $78.66 | +301 | 37.2K | +0.8% | +$23.7K | |
| 2025-10-03 | 2025-10-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $82.13 | +289 | 36.7K | +0.8% | +$23.7K | |
| 2025-07-02 | 2025-07-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $89.91 | +264 | 36.2K | +0.7% | +$23.7K | |
| D | 2025-05-14 | 2025-05-12 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $0.00 | +2,019 | 35.8K | +6% | $0 |
| 2025-04-03 | 2025-04-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $91.99 | +231 | 33.7K | +0.7% | +$21.2K | |
| 2025-01-06 | 2025-01-02 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $93.18 | +228 | 33.3K | +0.7% | +$21.2K | |
| 2024-12-03 | 2024-11-29 | ELAN | Elanco Animal Health Inc | BILBREY JOHN P | Dir | A - Grant | $0.00 | +18.2K | 78.4K | +30% | $0 | |
| 2024-11-15 | 2024-11-14 | TPR | Tapestry, Inc. | BILBREY JOHN P | Dir | A - Grant | $57.82 | +3,459 | 47.8K | +8% | +$200.0K | |
| 2024-10-03 | 2024-10-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $105.24 | +201 | 32.9K | +0.6% | +$21.2K | |
| 2024-07-03 | 2024-07-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $95.61 | +222 | 32.5K | +0.7% | +$21.2K | |
| D | 2024-05-15 | 2024-05-13 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $0.00 | +1,905 | 32.2K | +6% | $0 |
| D | 2024-05-03 | 2024-05-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | S - Sale+OE | $91.59 | -6,329 | 30.2K | -17% | -$579.7K |
| D | 2024-05-03 | 2024-05-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | M - OptEx | $62.04 | +6,329 | 36.6K | +21% | +$392.7K |
| 2024-04-03 | 2024-04-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $88.36 | +240 | 30.2K | +0.8% | +$21.2K | |
| 2024-01-04 | 2024-01-02 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $78.18 | +271 | 29.8K | +0.9% | +$21.2K | |
| 2023-12-04 | 2023-11-30 | ELAN | Elanco Animal Health Inc | BILBREY JOHN P | Dir | A - Grant | $0.00 | +20.4K | 60.2K | +51% | $0 | |
| D | 2023-11-03 | 2023-11-02 | TPR | Tapestry, Inc. | BILBREY JOHN P | Dir | A - Grant | $27.33 | +3,110 | 44.3K | +8% | +$85.0K |
| 2023-10-04 | 2023-10-02 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $72.76 | +292 | 29.4K | +1% | +$21.2K | |
| 2023-07-06 | 2023-07-03 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $76.32 | +278 | 28.9K | +1.0% | +$21.2K | |
| D | 2023-05-17 | 2023-05-15 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $0.00 | +2,220 | 28.6K | +8% | $0 |
| D | 2023-05-10 | 2023-05-09 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | M - OptEx | $71.65 | +5,703 | 32.0K | +22% | +$408.6K |
| D | 2023-05-10 | 2023-05-09 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | S - Sale+OE | $80.81 | -5,703 | 26.3K | -18% | -$460.9K |
| 2023-04-05 | 2023-04-03 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $72.95 | +291 | 26.3K | +1% | +$21.2K | |
| 2023-01-05 | 2023-01-03 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $78.40 | +271 | 25.8K | +1% | +$21.2K | |
| D | 2022-12-02 | 2022-11-30 | ELAN | Elanco Animal Health Inc | BILBREY JOHN P | Dir | A - Grant | $0.00 | +18.6K | 39.9K | +88% | $0 |
| D | 2022-11-16 | 2022-11-15 | TPR | Tapestry, Inc. | BILBREY JOHN P | Dir | A - Grant | $34.98 | +2,430 | 41.1K | +6% | +$85.0K |
| I | 2022-11-15 | 2022-11-11 | ELAN | Elanco Animal Health Inc | BILBREY JOHN P | Dir | P - Purchase | $13.24 | +7,500 | 41.7K | +22% | +$99.3K |
| 2022-10-05 | 2022-10-03 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $75.71 | +280 | 25.4K | +1% | +$21.2K | |
| 2022-07-06 | 2022-07-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $77.62 | +273 | 25.0K | +1% | +$21.2K | |
| I | 2022-05-13 | 2022-05-11 | ELAN | Elanco Animal Health Inc | BILBREY JOHN P | Dir | P - Purchase | $22.03 | +10.0K | 34.2K | +41% | +$220.3K |
| D | 2022-05-11 | 2022-05-09 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $0.00 | +2,317 | 24.6K | +10% | $0 |
| 2022-04-04 | 2022-04-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $75.16 | +283 | 22.2K | +1% | +$21.3K | |
| D | 2022-02-15 | 2022-02-14 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | M - OptEx | $71.76 | +5,389 | 26.8K | +25% | +$386.7K |
| D | 2022-02-15 | 2022-02-14 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | S - Sale+OE | $78.66 | -4,917 | 21.8K | -18% | -$386.8K |
| 2022-01-05 | 2022-01-03 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $81.13 | +262 | 21.4K | +1% | +$21.3K | |
| D | 2021-12-02 | 2021-11-30 | ELAN | Elanco Animal Health Inc | BILBREY JOHN P | Dir | A - Grant | $0.00 | +7,307 | 21.2K | +53% | $0 |
| D | 2021-11-05 | 2021-11-03 | TPR | Tapestry, Inc. | BILBREY JOHN P | Dir | A - Grant | $41.82 | +1,793 | 38.6K | +5% | +$75.0K |
| 2021-10-05 | 2021-10-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $76.91 | +276 | 21.0K | +1% | +$21.2K | |
| 2021-07-06 | 2021-07-01 | CL | Colgate-Palmolive | BILBREY JOHN P | Dir | A - Grant | $82.33 | +258 | 20.6K | +1% | +$21.2K |
Purchase Sale Sale after option exercise All abbreviations